Group 1 - The core viewpoint of the news is that Tongjing Life has seen a stock price increase of 5.03%, reaching 23.18 CNY per share, with a trading volume of 136 million CNY and a turnover rate of 4.41%, resulting in a total market capitalization of 3.768 billion CNY [1] - Tongjing Life, established on November 6, 2003, and listed on April 21, 2017, specializes in the research, production, and sales of in vitro diagnostic products under its own brand [1] - The revenue composition of Tongjing Life is as follows: 92.50% from reagents, 6.20% from instruments, 1.26% from services, and 0.04% from materials [1] Group 2 - Citic Prudential Fund's multi-strategy mixed fund (LOF) A (165531) has entered the top ten circulating shareholders of Tongjing Life, holding 1.2039 million shares, which is 0.87% of the circulating shares, with an estimated floating profit of approximately 1.3363 million CNY [2] - The fund was established on June 16, 2017, with a latest scale of 1.245 billion CNY, achieving a year-to-date return of 39.46%, ranking 2133 out of 8167 in its category, and a one-year return of 62.73%, ranking 1279 out of 8010 [2] Group 3 - The fund managers of Citic Prudential multi-strategy mixed fund (LOF) A are Jiang Feng and Wang Ying, with Jiang Feng having a tenure of 5 years and 171 days and a total fund asset scale of 5.782 billion CNY, achieving a best fund return of 123.41% during his tenure [3] - Wang Ying has a tenure of 8 years and 229 days with a total fund asset scale of 6.176 billion CNY, achieving a best fund return of 54.3% during her tenure [3]
透景生命股价涨5.03%,中信保诚基金旗下1只基金位居十大流通股东,持有120.39万股浮盈赚取133.63万元